The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy ...

Phibro Animal Health Corporation’s PAHC focus on advancing vaccine technologies is poised to drive growth in the upcoming quarters. The company’s global growth prospects look encouraging.

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday morning. Other analysts ...

Phibro Animal Health PAHC has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite ...

Morgan Stanley analyst Erin Wright maintained a Hold rating on Phibro Animal Health (PAHC – Research Report) today and set a price target of $25.00. The company’s shares closed yesterday at ...

Morgan Stanley analyst Erin Wright raised the firm’s price target on Phibro Animal Health (PAHC) to $25 from $20 and keeps an Equal Weight rating on the shares. Diversified Managed Care ...

StockNews.com downgraded shares of Phibro Animal Health (NASDAQ:PAHC – Free Report) from a strong-buy rating to a buy rating in a research report released on Friday. Other research analysts have also ...

Phibro Animal Health Corporation’s PAHC focus on advancing vaccine technologies is poised to drive growth in the upcoming quarters. The company’s global growth prospects look encouraging. Yet, adverse ...